AC

Altrium Capital Management

Description

Altrium Capital Management is an investment firm.

Investor Profile

Altrium Capital Management has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series C (100%)

Country Focus

  • Singapore (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Oncology
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Altrium Capital Management frequently co-invest with?

Amgen Ventures
North America, California, United States, San Francisco
Co-Investments: 1
MV
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
Kinled Holding
North America, New York, United States, New York
Co-Investments: 1
Droia Ventures
Europe, Luxembourg, Luxembourg, Luxembourg
Co-Investments: 1
Mirae Asset Venture Investment
Asia, Kyonggi-do, South Korea, Seongnam
Co-Investments: 1
Ally Bridge Group
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
Frazier Healthcare Partners
North America, Washington, United States, Seattle
Co-Investments: 1
Heritas Capital
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
EDBI
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Affinity Asset Advisors
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by Altrium Capital Management?

Hummingbird Bioscience

Woodlands, North Region, Singapore

Hummingbird Bioscience focuses on the discovery and early development of oncology drugs.

BiotechnologyHealth CareOncologyTherapeutics
Series CMay 18, 2021
Amount Raised: $125,000,000